Mitsui Chemicals Yönetim
Yönetim kriter kontrolleri 0/4
Mitsui Chemicals CEO'su Satoshi Ichimura, Apr2026 tarihinde atandı, in görev süresi bir yıldan az. şirketin hisselerinin 0.002% doğrudan sahiptir ve bu hisselerin değeri ¥ 15.87M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.7 yıl ve 2.3 yıldır.
Anahtar bilgiler
Satoshi Ichimura
İcra Kurulu Başkanı
n/a
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | less than a year |
| CEO sahipliği | 0.002% |
| Yönetim ortalama görev süresi | 1.7yrs |
| Yönetim Kurulu ortalama görev süresi | 2.3yrs |
Son yönetim güncellemeleri
Recent updates
Anlatı Güncellemesi • Sep 07
4183: Earnings Guidance And Capital Moves Will Shape A Balanced Outlook
Mitsui Chemicals' analyst price target has shifted from ¥2,350 to about ¥2,435. Analysts point to updated assumptions on fair value, discount rate, profit margins and future P/E as the main drivers of the change.Analiz Makalesi • Aug 07
Analyst Estimates: Here's What Brokers Think Of Mitsui Chemicals, Inc. (TSE:4183) After Its First-Quarter Report
It's been a good week for Mitsui Chemicals, Inc. ( TSE:4183 ) shareholders, because the company has just released its...
Anlatı Güncellemesi • Jul 30
4183: Treasury Share Disposal Will Support Long Term Upside As Earnings Multiple Re-Rates
Analysts have raised their price target for Mitsui Chemicals from ¥3,000 to about ¥3,355, explaining the change with updated assumptions for revenue growth, profit margins, and future P/E levels. What's in the News Mitsui Chemicals has scheduled a board meeting for Jun 24, 2026 to consider and approve the disposal of treasury shares, along with other business-related matters.
Anlatı Güncellemesi • Jul 15
4183: U.S. Oral Care Hub And Richer Multiple Will Limit Future Returns
Analysts have revised their 12 month price target for Mitsui Chemicals from ¥1,550 to ¥1,790, citing updated assumptions for slightly higher revenue growth, improved profit margins, and a modest increase in the future P/E multiple. What’s in the News for Mitsui Chemicals Mitsui Chemicals is shifting its global oral care headquarters to the U.S., aiming to make oral care a core growth pillar and position itself more as a solutions provider for dental patients and professionals.Anlatı Güncellemesi • Jul 01
4183: Buybacks And Treasury Share Disposal Plans Will Shape A Balanced Outlook
The analyst price target for Mitsui Chemicals has been revised from ¥2,251.67 to ¥2,350.00. Analysts cited updated assumptions around revenue growth, profit margin and future P/E as the basis for the change.Anlatı Güncellemesi • Jun 17
4183: Softer Margins And Oral Care Expansion Will Restrain Future Share Returns
Analysts have maintained their fair value estimate for Mitsui Chemicals at ¥1,550, while adjusting key assumptions including a lower discount rate, slightly softer revenue growth and profit margin expectations, and a higher future P/E multiple to reflect the current research backdrop. What’s in the News for Mitsui Chemicals Mitsui Chemicals’ U.S. subsidiary agreed to acquire Ultradent Products to expand the group’s global oral care business, combining Ultradent’s U.S. presence with Mitsui’s Kulzer operations in the EMEA region.Anlatı Güncellemesi • Jun 03
4183: Share Buybacks Will Support Long Term Upside As Earnings Multiple Re-Rates
Analysts are keeping their ¥3,000 price target for Mitsui Chemicals unchanged. They point to small model tweaks in the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in the overall outlook.Anlatı Güncellemesi • May 15
4183: Share Buybacks Will Support Long Term Upside As Earnings Multiple Re-Rates
Analysts have kept their fair value estimate for Mitsui Chemicals steady at ¥3,000 per share. The updated price target reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin and future P/E rather than a major shift in their overall view of the stock.Anlatı Güncellemesi • Apr 26
4183: Weaker Earnings Outlook And Margin Pressure Will Weigh On Future Returns
Analysts have raised Mitsui Chemicals' fair value estimate from ¥1,500 to ¥1,550, citing updated assumptions that combine a slightly higher discount rate and a modestly lower profit margin with a materially higher revenue growth outlook and a marginally lower future P/E multiple. What's in the News Mitsui Chemicals has launched a share repurchase program of up to 18,400,000 shares, or 4.89% of its share capital, for ¥30,000m, with plans to cancel treasury shares after repurchase and a program period running until July 31, 2026 (Key Developments).Anlatı Güncellemesi • Apr 12
4183: Share Buybacks Will Support Long Term Upside Despite Near Term Margin Pressure
Analysts have kept the fair value estimate for Mitsui Chemicals steady at ¥3,000 by refining assumptions on discount rate, revenue growth, profit margin, and future P/E, which together underpin the updated price target narrative. What's in the News Mitsui Chemicals has launched a share repurchase program to buy up to 18,400,000 shares, around 4.89% of its share capital, for ¥30,000m, with plans to cancel the repurchased shares and run the program through July 31, 2026 (Board meeting and buyback transaction announcements, February 5, 2026).Anlatı Güncellemesi • Mar 28
4183: Renewable Plastics And Buybacks Will Support Long Term Share Upside
Analysts have maintained their ¥3,000 price target for Mitsui Chemicals, noting that only minor adjustments to assumptions such as discount rate, revenue growth, profit margin, and future P/E have been made, and these do not materially change their overall view of the shares. What's in the News Mitsui Chemicals is part of a 14 company global supply chain across five countries and regions to produce renewable plastics for Sony's high performance audio visual products, with a focus on tracking and documenting GHG emissions across the chain and supporting Sony's move away from virgin fossil based plastics (Key Developments).Anlatı Güncellemesi • Mar 14
4183: Renewable Plastics Supply Chain Will Reshape Long-Term Earnings Profile
Analysts have reset their price target on Mitsui Chemicals from ¥5,400 to ¥3,000, reflecting updated assumptions for slightly lower discount rates, as well as revised expectations for revenue growth, profit margins, and future P/E levels. What's in the News Mitsui Chemicals joined thirteen other companies across five countries to build what is described as the world's first global supply chain for renewable plastics for use in Sony's high performance audio visual products, allowing tracking of greenhouse gas emissions across the chain and supporting Sony's goal to reduce virgin fossil based plastics (Key Developments).Analiz Makalesi • Feb 13
Mitsui Chemicals' (TSE:4183) Conservative Accounting Might Explain Soft Earnings
Shareholders appeared unconcerned with Mitsui Chemicals, Inc.'s ( TSE:4183 ) lackluster earnings report last week. Our...Analiz Makalesi • Feb 08
Earnings Miss: Mitsui Chemicals, Inc. Missed EPS By 63% And Analysts Are Revising Their Forecasts
As you might know, Mitsui Chemicals, Inc. ( TSE:4183 ) last week released its latest quarterly, and things did not turn...Analiz Makalesi • Feb 05
Why Investors Shouldn't Be Surprised By Mitsui Chemicals, Inc.'s (TSE:4183) P/E
With a price-to-earnings (or "P/E") ratio of 47.9x Mitsui Chemicals, Inc. ( TSE:4183 ) may be sending very bearish...Anlatı Güncellemesi • Feb 05
4183: Decarbonization Investments And Stock Split Plans Will Shape A Balanced Outlook
Analysts have lifted their fair value estimate for Mitsui Chemicals from ¥2,170.83 to ¥2,251.67, citing slightly lower discount rate assumptions, minor adjustments to long term revenue growth and profit margin forecasts, and a modestly higher future P/E multiple. What's in the News Mitsui Chemicals, Asahi Kasei, and Mitsubishi Chemical were selected for Japan's Fiscal 2025 HtA Support Program to support decarbonization and production conversion at two ethylene facilities in western Japan, with a stated investment scale of ¥21.2b and a maximum subsidy application amount of ¥10.4b (HtA Support Program announcement).Anlatı Güncellemesi • Jan 22
4183: Stock Split Plans And Updated Guidance Will Shape A Balanced Outlook
Analysts have revised their price target on Mitsui Chemicals from ¥4,250.91 to ¥2,170.83, citing updated assumptions around slightly lower discount rates, adjusted revenue growth and profit margin expectations, and a modestly different future P/E multiple. What's in the News Mitsui Chemicals has scheduled a board meeting for November 11, 2025, with an agenda that includes discussing a potential stock split (Key Developments).Anlatı Güncellemesi • Jan 07
4183: Future Stock Split And Margin Pressure Will Weigh On Returns
Analysts have adjusted their price target for Mitsui Chemicals from ¥3,000 to ¥1,500, citing updated assumptions for revenue growth, profit margins, and future P/E multiples. What's in the News Mitsui Chemicals scheduled a board meeting for November 11, 2025 to discuss a potential stock split (Key Developments).Analiz Makalesi • Dec 03
Mitsui Chemicals (TSE:4183) Has Announced A Dividend Of ¥75.00
Mitsui Chemicals, Inc. ( TSE:4183 ) will pay a dividend of ¥75.00 on the 25th of June. The dividend yield will be 3.9...Analiz Makalesi • Oct 23
Investors Appear Satisfied With Mitsui Chemicals, Inc.'s (TSE:4183) Prospects
When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Mitsui...Analiz Makalesi • Sep 22
Mitsui Chemicals' (TSE:4183) Dividend Will Be ¥75.00
Mitsui Chemicals, Inc. ( TSE:4183 ) has announced that it will pay a dividend of ¥75.00 per share on the 3rd of...Anlatı Güncellemesi • Sep 21
Specialty Chemicals Restructuring Will Unlock Sustainable Market Potential
The upward revision in Mitsui Chemicals’ price target is underpinned by a marginal improvement in consensus revenue growth forecasts and a slightly higher expected future P/E, resulting in the fair value estimate increasing from ¥4151 to ¥4251. What's in the News Revised H1 2025 earnings guidance: sales revenue JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, basic EPS JPY 40.03.Anlatı Güncellemesi • Sep 06
Specialty Chemicals Restructuring Will Unlock Sustainable Market Potential
With Mitsui Chemicals’ consensus analyst price target and key valuation metrics such as the discount rate and future P/E ratio all remaining effectively unchanged, analysts see no material change in fair value, maintaining the target at ¥4151. What's in the News Revised first-half FY2025 guidance: sales revenue expected at JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, and basic EPS JPY 40.03.
Yeni Anlatı • Jan 05
Yen Depreciation And Specialty Chemicals Surge Will Propel Operating Income And Revenue Growth
Yen depreciation and improved trade terms are expected to boost operating income in specialty chemicals, positively impacting revenue.CEO
Satoshi Ichimura (59 yo)
less than a year
Görev süresi
Mr. Satoshi Ichimura is President, CEO and Representative Director of Mitsui Chemicals, Inc since April 1, 2026. He was Managing Executive Officer and CSO at Mitsui Chemicals, Inc since April 2024 until Ap...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, President & Representative Director | less than a year | Veri yok | 0.0021% ¥ 15.9m | |
| Managing Executive Officer | 1.7yrs | Veri yok | Veri yok | |
| Managing Executive Officer CTO & Director | 1.7yrs | Veri yok | Veri yok | |
| Director of IR Department - Corporate Communicate Division | no data | Veri yok | Veri yok | |
| CHRO & Managing Executive Officer | less than a year | Veri yok | Veri yok | |
| Senior Managing Executive Officer & Representative Director | no data | Veri yok | 0.012% ¥ 94.2m | |
| Executive Officer & Senior VP of Digital Transformation Sector | 2.7yrs | Veri yok | Veri yok | |
| Senior Managing Executive Officer & President of Basic & Green Materials Business Sector | 4.7yrs | Veri yok | Veri yok | |
| Managing Executive Officer | 4.7yrs | Veri yok | Veri yok | |
| Managing Executive Officer | 1.7yrs | Veri yok | Veri yok | |
| Managing Executive Officer & President of Life & Healthcare Solutions Business Sector | 1.7yrs | Veri yok | Veri yok | |
| Managing Executive Officer & President of ICT Solutions Business Sector | less than a year | Veri yok | Veri yok |
1.7yrs
Ortalama Görev Süresi
62.5yo
Ortalama Yaş
Deneyimli Yönetim: 4183 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.7 yıl), bu da yeni bir ekibin varlığını gösteriyor.
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO, President & Representative Director | 1.3yrs | Veri yok | 0.0021% ¥ 15.9m | |
| Managing Executive Officer | no data | Veri yok | Veri yok | |
| Managing Executive Officer CTO & Director | less than a year | Veri yok | Veri yok | |
| Senior Managing Executive Officer & Representative Director | 1.3yrs | Veri yok | 0.012% ¥ 94.2m | |
| Director | less than a year | Veri yok | Veri yok | |
| Chairman | 8.3yrs | JP¥138.00m | 0.028% ¥ 214.9m | |
| Audit & Supervisory Board Member | 3.3yrs | Veri yok | Veri yok | |
| Audit & Supervisory Board Member | 2.3yrs | Veri yok | 0.010% ¥ 79.6m | |
| Independent Outside Director | 5.3yrs | Veri yok | 0.0016% ¥ 12.4m | |
| Independent Outside Director | 4.3yrs | Veri yok | 0.0010% ¥ 7.7m | |
| Independent Outside Director | 2.3yrs | Veri yok | Veri yok | |
| Audit & Supervisory Board Member | 3.3yrs | Veri yok | Veri yok |
2.3yrs
Ortalama Görev Süresi
65yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 4183 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.3 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/09/10 12:35 |
| Gün Sonu Hisse Fiyatı | 2026/09/10 00:00 |
| Kazançlar | 2026/06/30 |
| Yıllık Kazançlar | 2026/03/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Mitsui Chemicals, Inc. 19 Bu analistlerden 11, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Mikiya Yamada | Barclays |
| Takashi Enomoto | BofA Global Research |
| Yuta Nishiyama | Citigroup Inc |